Yoshihiko Uehara
Tohoku University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yoshihiko Uehara.
International Journal of Cancer | 1998
Keigo Yamamichi; Yoshihiko Uehara; Naomi Kitamura; Yasushi Nakane; Koshiro Hioki
Expression of CD44 and its variants is associated with clinically aggressive behavior of some human cancers. The present study was undertaken to determine the expression level of these CD44 mRNAs in relation to the clinico‐pathologic features and prognosis of gastric cancer. Using reverse transcription polymerase chain reaction followed by Southern blotting, we examined the expression of the standard and variant (v6 and v9) forms of CD44 mRNA in 73 cases of gastric cancer. We determined the ratio of mRNA expression in cancer tissue to normal tissue (T/N ratio) and evaluated the correlations of the ratio with clinico‐pathologic features, tumor progression and prognosis. The expression level of the standard form of CD44 (CD44s) mRNA correlated with peritoneal dissemination only, and that of CD44v9 mRNA did not significantly correlate with any clinico‐pathologic factor. The expression level of CD44v6 mRNA was significantly higher in patients with lymph node metastasis and liver metastasis. In 48 curatively resected patients, the expression level of CD44v6 mRNA correlated with the site of recurrence. Furthermore, there was a significant survival advantage in patients with low expression of CD44v6 mRNA compared with those with high expression. The level of CD44v6 mRNA expression may be a potential prognostic indicator and may be useful as a predictor for distant metastasis and recurrence in patients with gastric cancer. Int. J. Cancer (Pred. Oncol.) 79:256–262, 1998.© 1998 Wiley‐Liss, Inc.
Mechanisms of Ageing and Development | 2002
Tetsuya Ono; Yoshihiko Uehara; Yusuke Saito; Hironobu Ikehata
A vital question in the mutation theory of aging is whether mutation accumulates with age. If it does, what are the causes and consequences of the accumulation of mutation? The recent development of transgenic mice has made it possible to study mutation in different kinds of tissues and at a molecular level. An application of these mice to the study of age-dependent alteration has revealed that mutation does accumulate in the aging process. Studies have also revealed several important characteristics of mutation associated with aging. (1) The rate of age-dependent increase of mutant frequency varies among different types of tissue. (2) The rate is not in parallel with the cell proliferation rate of the tissue. (3) Some types of mutation are unique to specific tissues, suggesting the presence of a mechanism of mutation relative to tissue type. On the other hand, several kinds of knockout mice defective in DNA repair have been shown to exhibit tissue lesions and shortened life span. These characteristics provide a new view on the relationship between aging and the genome maintenance system. Here we review the current status of research on the correlation between mutation and aging undertaken by the use of transgenic and knockout mice.
Journal of Dental Research | 2006
Takashi Ohi; Yoshihiko Uehara; Masaki Takatsu; Mika Watanabe; Tetsuya Ono
Although the human periodontal ligament shows age-associated histological alterations, the molecular mechanisms are not yet understood. We previously found that COL1A1 gene expression declines with age. In this study, we asked whether DNA methylation in the regulatory region of the gene alters in the aging process, as a possible cause of the decline. The method used was a bisulfite modification of cytosine and nucleotide sequencing of DNA. While the 1st intron region was kept demethylated at young and old ages, the levels of methylation at most CpG sites in the proximal and distal regions of the promoter showed elevation at older ages. Analysis of the data indicates the possible importance of DNA hypermethylation in the promoter region for the age-associated decrease of COL1A1 gene expression.
Cancer Research | 2004
Tetsuya Ono; Hironobu Ikehata; Vishnu Priya Pithani; Yoshihiko Uehara; Yali Chen; Yoshitaka Kinouchi; Toru Shimosegawa; Yoshio Hosoi
In an attempt to evaluate the possible role of mutations in the age-dependent increase of tumor incidence, we studied the mutational burden that accumulates in the aging process in different parts of the digestive tract in mice. The mutations were monitored in lacZ genes integrated in the mouse genome. The digestive tract was divided into the esophagus, stomach, proximal, medial, and distal part of the small intestine, and the colon. Epithelial tissues were separated from these tissues with the exception of the esophagus, in which case the whole tissue was examined. At a young age, the mutant frequencies as well as the molecular nature of the mutations were similar among the tissues examined. In old age, on the other hand, mutant frequencies were elevated to different degrees among the tissues; they were high in the small intestine and colon, intermediate in the stomach, and low in the esophagus. The molecular characteristics of the mutations also revealed distinct tissue-specificity; there were elevated rates of a small deletion mutation in the esophagus, G:C to T:A transversion in the proximal small intestine, and multiple mutations in the distal small intestine and colon. The results indicate that different parts of the digestive tract suffer from different kinds of mutational stress in the aging process. The nature of the multiple mutations suggests the presence of a mutator phenotype based on an imbalance in deoxyribonucleotide pools.
Cancer Science | 2011
Atsuko Sato; Chieko Kudo; Hiroyuki Yamakoshi; Yoshihiko Uehara; Hisatsugu Ohori; Chikashi Ishioka; Yoshiharu Iwabuchi; Hiroyuki Shibata
Curcumin is a dietary constituent with tumor‐suppressing potential, inhibiting various pathways involved in carcinogenesis. However, because of its low bioavailability, the use of curcumin in in vivo trials has been limited. To overcome this problem, we synthesized more than 50 analogs and identified a monoketone analog, GO‐Y030, which has a 30‐fold higher potential to suppress tumor cell growth compared with curcumin. We investigated the inhibitory effect of GO‐Y030 on NF‐κB activation. In thyroid, pancreatic cancers and cholangiocarcinoma cells, in which NF‐κB is activated, NF‐κB activation was suppressed to 8–62% of the control value following treatment with 1 μM GO‐Y030, an effect comparable to that of 10 μM curcumin. Direct inhibition of IKKβ kinase activity and suppression of nuclear translocation of the NF‐κB p65 subunit were observed. The 50% growth inhibition concentrations of GO‐Y030 ranged from one‐11th to one‐14th of those of curcumin. GO‐Y030 also induced cell death comparable to that induced by curcumin but at a 10‐fold lower concentration. In pancreatic and thyroid cancer cells, the growth‐inhibitory effect of GO‐Y030 was 4‐ and 15‐fold greater, respectively, than that of curcumin. GO‐Y030 was a much stronger inducer of apoptosis compared with curcumin. The enhanced potency of GO‐Y030 may make it more useful than curcumin, which suffers from low bioavailability. GO‐Y030 is a good lead compound for the development of useful compounds for practical cancer chemotherapy. (Cancer Sci 2011; 102: 1045–1051)
Radiation Research | 2010
Yoshihiko Uehara; Yasuko Ito; Keiko Taki; Mitsuru Nenoi; Kazuaki Ichinohe; Shingo Nakamura; Satoshi Tanaka; Yoichi Oghiso; Kimio Tanaka; Tsuneya Matsumoto; Tatjana Paunesku; Gayle E. Woloschak; Tetsuya Ono
Abstract Changes in gene expression profiles in mouse liver induced by long-term low-dose-rate &ggr; irradiation were examined by microarray analysis. Three groups of male C57BL/6J mice were exposed to whole-body radiation at dose rates of 17–20 mGy/day, 0.86–1.0 mGy/day or 0.042–0.050 mGy/day for 401–485 days with cumulative doses of approximately 8 Gy, 0.4 Gy or 0.02 Gy, respectively. The gene expression levels in the livers of six animals from each exposure group were compared individually with that of pooled sham-irradiated animals. Some genes revealed a large variation in expression levels among individuals within each group, and the number of genes showing common changes in individuals from each group was limited: 20 and 11 genes showed more than 1.5-fold modulation with 17–20 mGy/day and 0.86–1.0 mGy/day, respectively. Three genes showed more than 1.5-fold modulation even at the lowest dose-rate of 0.04–0.05 mGy/day. Most of these genes were down-regulated. RT-PCR analysis confirmed the expression profiles of the majority of these genes. The results indicate that a few genes are modulated in response to very low-dose-rate irradiation. The functional analysis suggests that these genes may influence many processes, including obesity and tumorigenesis.
Mutation Research\/dnaging | 1993
Yoshinori Miyamura; Riichi Tawa; Akio Koizumi; Yoshihiko Uehara; Akihiro Kurishita; Hiromu Sakurai; Shigetoshi Kamiyama; Tetsuya Ono
DNA methylation is known to change with age in several mammalian species. Here we have examined the effect of dietary energy restriction on this age-associated change in liver DNA of C3H/SHN mice. The total 5-methyldeoxycytidine level in the genome decreased slightly soon after energy restriction started. The effect, however, diminished with time and no appreciable difference was detected at middle and old ages. The degree of methylation at the c-myc gene, on the other hand, was not affected by energy restriction at early periods, but the age-dependent alterations at later ages were repressed. This is a new finding to show that DNA methylation is one of the molecular indices of aging affected by energy restriction. It suggests an importance of DNA methylation in the aging process.
Genesis | 2000
Yoshihiko Uehara; Chisato Mori; Tetsuo Noda; Naomi Kitamura
Summary: While the targeted disruption of a gene is a powerful tool for investigating the physiological functions of that gene, disruption of a gene essential for embryogenesis leads to embryonic death. Rescue of the defect(s) causing embryonic death should promote survival, thus permitting further evaluation of the roles that the gene plays later in the developmental process. Disruption of the gene for mouse hepatocyte growth factor/scatter factor (HGF/SF) leads to middle‐stage embryonic lethality because of a defect in placental development. Here we report that a single injection of HGF/SF at embryonic day 9.5 (E9.5) into the amniotic cavity of HGF/SF−/− embryos rescued the placental defect and resulted in the survival of the embryos until term. Histological analysis suggested that HGF/SF is also required at the late stage of development for tissue organogenesis. Thus, injection of a secreted factor can be a useful method to rescue the defects causing embryonic lethality. genesis 27:99–103, 2000.
Radiation Research | 2010
Naohito Okudaira; Yoshihiko Uehara; Kazuo Fujikawa; Nao Kagawa; Akira Ootsuyama; Toshiyuki Norimura; Ken-ichi Saeki; Takehiko Nohmi; Ken-ichi Masumura; Tsuneya Matsumoto; Yoichi Oghiso; Kimio Tanaka; Kazuaki Ichinohe; Shingo Nakamura; Satoshi Tanaka; Tetsuya Ono
Abstract The effect of dose rate on radiation-induced mutations in two somatic tissues, the spleen and liver, was examined in transgenic gpt delta mice. These mice can be used for the detection of deletion-type mutations, and these are the major type of mutation induced by radiation. The dose rates examined were 920 mGy/min, 1 mGy/min and 12.5 µGy/min. In both tissues, the number of mutations increased with increasing dose at each of the three dose rates examined. The mutation induction rate was dependent on the dose rate. The mutation induction rate was higher in the spleen than in the liver at the medium dose rate but was similar in the two tissues at the high and low dose rates. The mutation induction rate in the liver did not show much change between the medium and low dose rates. Analysis of the molecular nature of the mutations indicated that 2- to 1,000-bp deletion mutations were specifically induced by radiation in both tissues after high- and low-dose-rate irradiation. The occurrence of deletion mutation without any sequence homology at the break point was elevated in spleen after high-dose-rate irradiation. The results indicate that the mutagenic effects of radiation in somatic tissues are dependent on dose rate and that there is some variability between tissues.
Journal of Radiation Research | 2014
Bing Wang; Kaoru Tanaka; Bin Ji; Maiko Ono; Yaqun Fang; Yasuharu Ninomiya; Kouichi Maruyama; Nakako Izumi-Nakajima; Nasrin Begum; Makoto Higuchi; Akira Fujimori; Yoshihiko Uehara; Tetsuo Nakajima; Tetsuya Suhara; Tetsuya Ono; Mitsuru Nenoi
The cause and progression of Alzheimers disease (AD) are poorly understood. Possible cognitive and behavioral consequences induced by low-dose radiation are important because humans are exposed to ionizing radiation from various sources. Early transcriptional response in murine brain to low-dose X-rays (100 mGy) has been reported, suggesting alterations of molecular networks and pathways associated with cognitive functions, advanced aging and AD. To investigate acute and late transcriptional, pathological and cognitive consequences of low-dose radiation, we applied an acute dose of 100-mGy total body irradiation (TBI) with X-rays to C57BL/6J Jms mice. We collected hippocampi and analyzed expression of 84 AD-related genes. Mouse learning ability and memory were assessed with the Morris water maze test. We performed in vivo PET scans with 11C-PIB, a radiolabeled ligand for amyloid imaging, to detect fibrillary amyloid beta peptide (Aβ) accumulation, and examined characteristic AD pathologies with immunohistochemical staining of amyloid precursor protein (APP), Aβ, tau and phosphorylated tau (p-tau). mRNA studies showed significant downregulation of only two of 84 AD-related genes, Apbb1 and Lrp1, at 4 h after irradiation, and of only one gene, Il1α, at 1 year after irradiation. Spatial learning ability and memory were not significantly affected at 1 or 2 years after irradiation. No induction of amyloid fibrillogenesis or changes in APP, Aβ, tau, or p-tau expression was detected at 4 months or 2 years after irradiation. TBI induced early or late transcriptional alteration in only a few AD-related genes but did not significantly affect spatial learning, memory or AD-like pathological change in mice.